XML 25 R15.htm IDEA: XBRL DOCUMENT

Income Taxes	9 Months Ended
Oct. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 8. INCOME TAXES Provision for Income Taxes The CARES Act, among other things, includes provisions related to refundable payroll tax credits, deferment of employer side social security payments, net operating loss utilization and carryback periods, modifications to the net interest deduction limitations, increased limitations on qualified charitable contributions, and technical corrections to tax depreciation methods for qualified improvement property. At the end of each quarter, the Company estimates its effective income tax rate pursuant to ASC 740. The rate for the period consists of the tax rate expected to be applied for the full year to ordinary income adjusted for any discrete items recorded in the period. Discrete items that were recognized Year-to-Date 2020 included the vesting of certain share-based compensation awards and the technical corrections aspect of the CARES Act related to carryback of net operating losses (“NOLs”) in years beginning in 2017. The effective income tax rate for the full year is determined by the level and composition of income (loss) before income taxes, excluding discrete items as discussed above, which is subject to federal, state, local and foreign income taxes. The Company recorded a tax expense at an overall effective tax rate of 27.7% and 27.2% for Third Quarter 2020 and Third Quarter 2019, respectively and tax benefit of 39.3% and 51.9% for Year-to-Date 2020 and Year-to-Date 2019, respectively. The Year-to-Date 2020 rate reflects the estimated tax benefits as a result of the CARES Act. The Year-to-Date 2019 rates reflect the tax benefits resulting from the change in status of various foreign jurisdictions.

Income Taxes

9 Months Ended

Oct. 30, 2020

NOTE 8. INCOME TAXES

Provision for Income Taxes

The CARES Act, among other things, includes provisions related to refundable payroll tax credits, deferment of employer side social security payments, net operating loss utilization and carryback periods, modifications to the net interest deduction limitations, increased limitations on qualified charitable contributions, and technical corrections to tax depreciation methods for qualified improvement property.

At the end of each quarter, the Company estimates its effective income tax rate pursuant to ASC 740. The rate for the period consists of the tax rate expected to be applied for the full year to ordinary income adjusted for any discrete items recorded in the period.

Discrete items that were recognized Year-to-Date 2020 included the vesting of certain share-based compensation awards and the technical corrections aspect of the CARES Act related to carryback of net operating losses (“NOLs”) in years beginning in 2017. The effective income tax rate for the full year is determined by the level and composition of income (loss) before income taxes, excluding discrete items as discussed above, which is subject to federal, state, local and foreign income taxes.

The Company recorded a tax expense at an overall effective tax rate of 27.7% and 27.2% for Third Quarter 2020 and Third Quarter 2019, respectively and tax benefit of 39.3% and 51.9% for Year-to-Date 2020 and Year-to-Date 2019, respectively. The Year-to-Date 2020 rate reflects the estimated tax benefits as a result of the CARES Act. The Year-to-Date 2019 rates reflect the tax benefits resulting from the change in status of various foreign jurisdictions.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details